Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisa Michelle Kallebo Insider Profile
4 Followers
Lisa Michelle Kallebo, Chief Accounting Officer at ADC Therapeutics, holds 36.00K shares in ADC Therapeutics (Ticker: ADCT).
Lisa Michelle Kallebo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Lisa Michelle Kallebo's holdings
Insider Roles
Chief Accounting Officer
Roles that Lisa Michelle Kallebo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lisa Michelle Kallebo
Lisa Michelle Kallebo's Trading History
List of latest transactions for each holding click on a transaction to see Lisa Michelle Kallebo's performance on stock
You May Also Like
Lisa Michelle Kallebo insider profile FAQ
What is the percentage of profitable transactions made by Lisa Michelle Kallebo?
The percentage of profitable transactions made by Lisa Michelle Kallebo is ―.
What is the average return per transaction made by Lisa Michelle Kallebo?
The average return per transaction made by Lisa Michelle Kallebo is ―.
What stocks does Lisa Michelle Kallebo hold?
Lisa Michelle Kallebo holds: ADCT stocks.
What was Lisa Michelle Kallebo’s latest transaction?
Lisa Michelle Kallebo latest transaction was an Uninformative Sell of $20.35K.
What was Lisa Michelle Kallebo's most profitable transaction?
Lisa Michelle Kallebo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lisa Michelle Kallebo's role in ADC Therapeutics?
Lisa Michelle Kallebo's role in ADC Therapeutics is Chief Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.